Journal profile

Current neuropharmacology

Publisher: Bentham Science Publishers
ISSN1570-159X | 1875-6190 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
4.36
Citation rate 7.33 2,374 total citations
h5-index 60 h5 depth signal
Cited share 84.4% 287 of 340
Total citations 2,374 Citation footprint
Metric signal 7.05 External metric anchor
Self-citation 0.8% 19 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

China 502
Italy 306
United States 261
India 152
Spain 77

Citing Fields of Research

Neurodegenerative Disorders 580
Neurosciences 440
Psychiatry 282
Brain Neurological Disorders 145
Substance Abuse 134

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 2,390 Articles tracked across the journal lifetime
Indexed publication set 340 287 cited publications
Last 12 months 375 31.3 publications/month
Open access share 25.6% 96 OA publications in the last year
Leading citing country China 502 citing publications
Leading citing field Neurodegenerative Disorders 580 citing publications
Latest tracked publication 14 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v13n1, 2015-
PubMed
v3, 2005-
PMC
Active Coverage

Research Focus & Classification

Indexed Subjects

Neurodegenerative Disorders Neurosciences Psychiatry Anesthetic & Pain Medicine Neuromuscular Disorders

Broad Categories

Neurology Pharmacology Psychiatry Neurosciences Neurodegenerative Disorders Substance Abuse Neuromuscular Disorders Anesthetic & Pain Medicine

MeSH Descriptors

Central Nervous System Agents Neuropharmacology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Mareli Vazquez-Barreto, Mariana Ugarte-Rocha, Abraham Flores Vargas et al.
Mental disorders are among the leading causes of non-fatal health loss worldwide and are associated with significant individual, social, and economic burdens. On the other hand, neuropathic pain affects approximately 7-8% of the world's ...
03
Rafael Lara-Estrada, Mauricio Molina-Gonzalez, Isaac González-Santoyo et al.
Environmental exposure to lead (Pb), manganese (Mn), and cadmium (Cd) damages the Blood-Brain Barrier (BBB) and the Neurovascular Unit (NVU) through a combination of pathways, including endothelial and astrocyte remodeling, transport dys...
04
Wenxiu Guo, Weisheng Huang, Ximan Weng et al.
Background/Objective: Pregabalin is a γ-aminobutyric acid (GABA) analog. It is prescribed for neuropathic pain, fibromyalgia, anxiety disorders, and seizures. Pregabalin misuse and abuse have increased rapidly worldwide in recent years, ...
06
Lei Wang, Huan Ouyang, Jinling Zhang et al.
Introduction: Transcutaneous auricular Vagus Nerve Stimulation (taVNS) may improve cognition in Mild Cognitive Impairment (MCI), but its electrophysiological correlates remain unclear. We explored whether parietal delta-band changes were...

Bibliographical & Catalog Notes

Title from cover.

Print issues ceased with v. 5, no. 4 (Dec. 2007)

Also issued online.